Deferasirox
A triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA.
Year introduced: 2019 (2000)
PubMed search builder options
Subheadings:
Tree Number(s): D02.241.223.100.250, D02.455.426.559.389.127.266, D03.383.129.799.363
MeSH Unique ID: D000077588
Registry Number: V8G4MOF2V9
Entry Terms:
- 4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid
- ICL670A
- ICL 670
- ICL-670
- ICL670
- Exjade
- ICL 670A
- ICL-670A
Pharmacologic Action: